Key Companies - Middle East & Africa Animal Healthcare Industry

 

During the projected period, the Middle East and Africa's rising dietary need for animal-based products is anticipated to drive market expansion. The region's tremendous expansion of animal farming has also increased need for more effective animal health services to promote food safety. The United States Department of Agriculture (USDA) predicted that Saudi Arabia would produce 650,000 MT of chicken meat in 2018 and 700,000 MT of chicken meat in 2019. The regional governments in the Middle East and Africa frequently host seminars to disseminate knowledge about enhancing poultry production.

The market for Animal Healthcare in the Middle East & Africa is anticipated to reach US$ 3,883.0 million in 2023 and grow at a CAGR of 5.2% from 2023 to 2030.

Top Companies in the Middle East & Africa Animal Healthcare Industry

Zoetis Inc

.: Established in 1950. United States headquarters.  Animal health products from Zoetis include parasiticides, vaccinations, anti-infectives, and diagnostics. Production animals (cattle, pigs, poultry, etc.) account for slightly less than half of the company's overall revenue, while companion animal products (dogs, horses, and cats) account for more than half of the remaining revenue. While its overseas business is just slightly slanted towards producing animals, its domestic industry is strongly skewed towards companion animals. The company, which was once Pfizer's animal health division, has the greatest market share in the sector. Zoetis reports that its acquisition of Jurox, a major supplier of livestock and companion animal products, has been completed.

Elanco

: United States headquarters.  Otitis externa in dogs worldwide rights of treatment centred in Greenfield, Indiana. The product comprises the active ingredients terbinafine, florfenicol, and betamethasone acetate and is used as veterinary medicine to treat canine ear infections. KindredBio (Jun 2021), Bayer Animal Health (Aug 2019), and Prevtec Microbia are the most recent acquisitions. 

Merck & Co., Inc.:

Established in 1891. United States headquarters. Merck produces pharmaceuticals to treat a variety of diseases in a number of therapeutic fields, such as cancer, infections, and cardiometabolic disease. The company's immuno-oncology platform is expanding as a significant contributor to overall sales in the cancer market. The corporation also operates a sizable vaccination division that offers vaccines for shingles, hepatitis B, paediatric illnesses, and HPV. Merck also offers medicines for animal health. Geographically speaking, the United States accounts for just under half of the company's sales. Acquisition boosts pipeline with a new candidate for ulcerative colitis, Crohn's disease, and other autoimmune disorders and provides industry-leading research capability.

Boehringer Ingelheim GmbH:

Built in 1885. Head office in Germany. 10 brands of pharmaceuticals. Brands like Antistax®, Bisolvon®, Buscopan®, Dulcolax®, Eve®, Mucoangin®, Mucosolvan®, Pharmaton®, Thomapyrin®, and Zantac® are among those offered by the Consumer Health Care division. These medications work effectively for treating colds and coughs, sore throats, generalised discomfort, gastrointestinal issues, and deficiencies in vitamins and minerals that are essential for both physical and mental health. The most recent acquisitions include NBE-Therapeutics (Dec 2020), AbeXXa Biologics (Sep 2021), and Trutino Biosciences (Jun 2022).

Ceva:

Established in 1999. Head office in the United States. Intellectual property for signal processing is licenced by CEVA Inc. The company assists in the production of devices for a variety of end markets through relationships with semiconductor firms and original equipment manufacturers globally. OEMs and semiconductor firms opt to sell goods to wireless, consumer, automotive, and Internet of Things businesses that use CEVA technology. The company's primary sources of income include licencing fees, related income, and royalties from the sales of items that use its intellectual property. Additionally, CEVA sells and offers training for development systems. Ingram Micro Commerce & Lifecycle Services has been fully acquired by CEVA Logistics, a division of CMA CGM Group.

Bayer AG:

It was founded in 1863. Dr. Headquarters are located in Leverkusen, Germany. Bayer is a German conglomerate involved in healthcare and agriculture. Healthcare accounts for about half of the company's revenue and comprises prescription medications, vitamins, and other consumer healthcare items. The company has a crop science division that comprises seeds, insecticides, herbicides, and fungicides, which it expanded after acquiring Monsanto.v FarmLead (Jan 2023), Blackford Analysis (Jan 2023), and Targenomix (Nov 2022) are the most recent acquisitions.

Evonik Industries AG:

Established in 2007. German headquarters are in Essen. German chemical manufacturer Evonik Industries sells both specialty and common chemical products. In 80% of its businesses, it holds the number-one to third position in the market. Europe accounts for about 45% of revenue, while the major markets of North America and Asia each contribute about 25%. Specialty additives, smart materials, nutrition and care, and performance materials make up the company's four main business segments. Porocel is successfully acquired by Evonik.

Definition

: Clinical services provided by veterinary clinics include the care of sick animals and the management of production-limiting conditions.